Marchini Antonio, Rappold Gudrun, Schneider Katja U
German Cancer Research Center (DKFZ) and Inserm U375, Heidelberg, Germany.
Arch Physiol Biochem. 2007 Jun;113(3):116-23. doi: 10.1080/13813450701531201.
The Short Stature Homeobox-containing Gene SHOX was identified as the genetic cause of the short stature phenotype in patients with Turner Syndrome and in certain patients with idiopathic short stature. Shortly after, SHOX mutations were also associated with the growth failure and skeletal deformities seen in patients with Léri - Weill dyschondrosteosis and Langer mesomelic dysplasia. Today it is estimated that SHOX mutations occur with an incidence of roughly 1:1,000 in newborns, making mutations of this gene one of the most common genetic defects leading to growth failure in humans. This review summarises the involvement of SHOX in several short stature syndromes and describes recent advances in our understanding of SHOX functions and regulation. We also discuss the current evidence in the literature that points to a role of this protein in growth and bone development. These studies have improved our knowledge of the SHOX gene and protein functions, and have given insight into the etiopathogenesis of short stature. However, the exact role of SHOX in bone development still remains elusive and poses the next major challenge for researchers in this field.
含矮小同源框基因SHOX被确定为特纳综合征患者以及某些特发性矮小患者身材矮小表型的遗传原因。此后不久,SHOX突变也与勒里-韦伊软骨发育不全和朗格中肢发育不全患者出现的生长衰竭和骨骼畸形有关。如今估计,新生儿中SHOX突变的发生率约为1:1000,使得该基因突变成为导致人类生长衰竭的最常见遗传缺陷之一。本综述总结了SHOX在几种矮小综合征中的作用,并描述了我们对SHOX功能和调控理解的最新进展。我们还讨论了文献中目前指向该蛋白在生长和骨骼发育中作用的证据。这些研究增进了我们对SHOX基因和蛋白功能的了解,并深入了解了矮小的发病机制。然而,SHOX在骨骼发育中的确切作用仍然难以捉摸,这对该领域的研究人员构成了下一个重大挑战。